Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Shuo Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8293-8937; OpenAlex author ID A5091538222. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Deciphering the senescence-based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel bulk and single-cell transcriptome data. First author DOI 10.1002/iub.70001↗
  2. LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. Last author DOI 10.1016/j.clinsp.2022.100047↗
  3. CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1. Co-author DOI 10.1155/2022/1911592↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yeting Lu · 3 shared papers, 2022–2025 · strength 0.58
  2. Xinhua Zhou · 2 shared papers, 2022–2025 · strength 0.41
  3. Xiang Wu · 1 shared paper, 2025 · strength 0.25
  4. Dongjian Ying · 1 shared paper, 2022 · strength 0.16
  5. Xinhua Zhou · 1 shared paper, 2022 · strength 0.16
  6. Yuan Tian · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.